Skip to main content
Clinical Trials/NCT04217928
NCT04217928
Unknown
Not Applicable

Comparison of Arthroscopic Debridement and Arthroscopic Hemi-Trapeziectomy With Mini TightRope on Patients With Thumb Carpometacarpal Joint Osteoarthritis - A Prospective Randomized Single-Blinded Controlled Trial

Chinese University of Hong Kong1 site in 1 country60 target enrollmentStarted: December 10, 2019Last updated:

Overview

Phase
Not Applicable
Enrollment
60
Locations
1
Primary Endpoint
Kapandji Score

Overview

Brief Summary

Patients with thumb carpometacarpal joint osteoarthritis usually suffer from pain, joint enlargement, inflammation, deformity and loss of function. Conservative treatments usually are the first-line interventions, unfortunately some of the patients do not response to such treatments and surgical treatment will then be considered.

Compare to other traditional surgical techniques, arthroscopic techniques has resulted in the potential to treat osteoarthritis in a minimally invasive approach, avoiding the need for a larger incision. Other advantages of arthroscopy include less scarring and joint contracture, less risk of neurovascular injury, improved appearance, limited morbidity and quicker recovery. Although arthroscopic methods have been proved to be effective, there is lack of high-level evidence based studies to conclude one operation is superior to another. Hence, this study is designed to investigate outcomes of the two arthroscopic surgical methods (arthroscopic debridement vs arthroscopic hemi-trapeziectomy with Mini TightRope). The result of this study is expected to provide significant evidence based clinical data for surgeons worldwide on treating the thumb carpometacarpal joint osteoarthritis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Outcomes assessor and biostatistician will be blinded

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with Eaton and Glickel stage II and III of thumb carpometacarpal joint osteoarthritis
  • Age≥18 years old
  • Failed to response to nonsurgical/conservative treatments including orthoses/splinting, activity modification, oral analgesics (e.g. nonsteroidal anti-inflammatory drugs), strengthening/flexibility exercises, and injections of corticosteroid or hyaluronic acid
  • Willing to receive surgery

Exclusion Criteria

  • Patients received previous thumb surgery proximal to the interphalangeal joint (IPJ)
  • Patients with prior traumatic thumb injuries (e.g. fracture, dislocation)
  • Patients with significant metacarpophalangeal joint (MCPJ) pain
  • With concurrent procedures on the thumb, e.g. ganglion removal, trigger thumb release

Outcomes

Primary Outcomes

Kapandji Score

Time Frame: Post-op 24 months

A tool for assessing the opposition of the thumb

Key and Tip Pinch

Time Frame: Post-op 24 months

Will be measured in kg

Range of Motion (ROM)

Time Frame: Post-op 24 months

ROM of interphalangeal joint and metacarpal joint of thumb will be measured

Complications

Time Frame: Post-operative up to 2 years

Any complications related to the surgery will be documented

Disability of Arm, Shoulder and Hand (DASH) questionnaire

Time Frame: Post-op 24 months

Specially designed tool to assess upper extremity disability and symptoms

Visual Analogue Scale (VAS) Pain Score at Rest and Exertion

Time Frame: Post-op 24 months

VAS pain score at rest and exertion will be measured post-operatively

Short-Form Survey (SF-36)

Time Frame: Post-op 24 months

Generic health status instrument to assess quality of life

Patients' Satisfaction Score

Time Frame: Post-op 24 months

To grade the subjects' satisfaction regarding to their thumb conditions (0=totally not satisfied; 10=fully satisfied)

Grip Strength

Time Frame: Post-op 24 months

Will be measured in kg

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Chu Kay MAK

Associate Consultant and Clinical Assistant Professor (Honorary)

Chinese University of Hong Kong

Study Sites (1)

Loading locations...

Similar Trials